Patient-reported outcomes for HIV: the future of long-acting injectables and antiretroviral therapy evaluations

*Author for correspondence:

Department of Pharmacy, University at Buffalo, School of Pharmacy & Pharmaceutical Sciences, Buffalo, NY 14214, USA

Department of Pharmacy, Center for Integrated Global Biomedical Sciences, Buffalo, NY 14214, USA

Department of Pharmacy, Catholic Health System, Buffalo, NY 14214, USA

View original article

0 0 0 0 0 0 0

Comments (0)